InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001156039-23-000026 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-03 2023-03-01+ ELV Haytaian Peter D EVP, Pres Carelon, CarelonRx F - Tax $468.80 -6,076 11.4K -35% -$2.85M
DM 2023-03-03 2023-03-01 ELV Haytaian Peter D EVP, Pres Carelon, CarelonRx A - Grant $0.00 +12.0K 23.4K +106% $0
D 2023-03-03 2023-03-01 ELV Haytaian Peter D EVP, Pres Carelon, CarelonRx A - Grant $0.00 +8,812 8,812 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-02 F D 5,469 $468.78 17,893 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
2 Common Common Stock 2023-03-01 A A 2,292 $0.00 13,646 D — — (F2) Represents restricted share units. Restrictions lapse as follows: 764 shares each on 3/1/2024, 3/1/2025 and 3/1/2026.
3 Common Common Stock 2023-03-01 F D 607 $469.03 11,354 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
4 Common Common Stock 2023-03-01 A A 9,716 $0.00 23,362 D — — (F3) Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
5 Derivative Employee Stock Option (Right to Buy) 2023-03-01 A A 8,812 $0.00 8,812 D $469.03 · — to 2033-03-01 8,812 Common Stock (F4) The option represents a right to purchase a total of 8,812 shares, and is exercisable in two installments of 2,937 shares each and one installment of 2,938 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.